Who
Brian Druker
Director
Company insider
Files Form 4 as: Director, Amgen; Director, Vincerx Pharma.
In numbers
- Trades disclosed
- 16
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 2
- Companies where not an officer
- 2
- First trade
- 31 Jul 2018
- Last trade
- 19 May 2026
- Last filed
- 21 May 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 19 May 2026filed 21 May 2026 | AMGN AmgenBiotechnology | SEC FORM 4 Code A | —665 at $0.00 | filing |
| 19 May 2026filed 21 May 2026 | AMGN AmgenBiotechnology | SEC FORM 4 Code A | —665 at $0.00 | filing |
| 23 May 2025filed 28 May 2025 | AMGN AmgenBiotechnology | SEC FORM 4 Code A | —809 at $0.00 | filing |
| 31 May 2024filed 4 Jun 2024 | AMGN AmgenBiotechnology | SEC FORM 4 Code A | —719 at $0.00 | filing |
| 23 May 2024filed 28 May 2024 | Vincerx Pharmaoption or derivative | SEC FORM 4 Code A | —15,000 at $0.00 | filing |
| 25 May 2023filed 30 May 2023 | Vincerx Pharmaoption or derivative | SEC FORM 4 Code A | —15,000 at $0.00 | filing |
| 19 May 2023filed 23 May 2023 | AMGN AmgenBiotechnology | SEC FORM 4 Code A | —939 at $0.00 | filing |
| 26 May 2022filed 31 May 2022 | Vincerx Pharmaoption or derivative | SEC FORM 4 Code A | —15,000 at $0.00 | filing |
| 17 May 2022filed 19 May 2022 | AMGN AmgenBiotechnology | SEC FORM 4 Code A | —855 at $0.00 | filing |
| 18 May 2021filed 20 May 2021 | AMGN AmgenBiotechnology | SEC FORM 4 Code A | —837 at $0.00 | filing |
| 13 May 2021filed 14 May 2021 | Vincerx Pharmaoption or derivative | SEC FORM 4 Code A | —20,000 at $0.00 | filing |
| 23 Dec 2020filed 28 Dec 2020 | Vincera Pharmaoption or derivative | SEC FORM 4 Code A | —6,667 at $0.00 | filing |
| 23 Dec 2020filed 28 Dec 2020 | Vincera Pharma | SEC FORM 4 Code A | —54,806 | filing |
| 5 May 2020filed 7 May 2020 | AMGN AmgenBiotechnology | SEC FORM 4 Code A | —846 at $0.00 | filing |
| 3 May 2019filed 7 May 2019 | AMGN AmgenBiotechnology | SEC FORM 4 Code A | —1,127 at $0.00 | filing |
| 31 Jul 2018filed 2 Aug 2018 | AMGN AmgenBiotechnology | SEC FORM 4 Code A | —678 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
No trade we could place in a sector.